| Q38885032 | Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial |
| Q40559239 | Assessing the efficacy of chloroquine and sulfadoxine–pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo |
| Q35891386 | Chemotherapy of drug-resistant malaria |
| Q36795473 | Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya |
| Q35013414 | Increasing antimalarial drug resistance in Uganda and revision of the national drug policy |
| Q33955360 | Malaria deaths in visitors to Canada and in Canadian travellers: a case series |
| Q47833599 | Malaria in travelers. Epidemiology, disease, and prevention |
| Q36372830 | Microscopy and molecular biology for the diagnosis and evaluation of malaria in a hospital in a rural area of Ethiopia. |
| Q33971977 | Modelling a predictable disaster: the rise and spread of drug-resistantmalaria |
| Q34030483 | Survey of use of malaria prevention measures by Canadians visiting India. |
| Q35081899 | Urban malaria and associated risk factors in Jimma town, south-west Ethiopia |